SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating
We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash...
Stay updated with breaking news from Surmodics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash...
Chicago private equity firm GTCR has inked a deal to buy the Eden Prairie-based medtech company Surmodics Inc.
Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Lake Street Capital in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $43.00 target price on the stock. Lake Street Capital’s price target points to a potential upside of 2.14% from the company’s […]
NEW YORK, May 29, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Surmodics, Inc. and its board of directors concerning the proposed acquisition of the...
-- Surmodics reported Wednesday a swing to earnings in fiscal Q2 as sales jumped more than forecast. Shares jumped 31% as intraday trading volume climbed to more than 127,000 versus the stock's...